TOPIC 453: A DIGITAL TOOL TO INTEGRATE CANCER PREVENTION WITHIN PRIMARY CARE.

主题 453：将癌症预防纳入初级保健的数字工具。

• 批准号: 10975542
• 负责人: GRACE CHEN
• 金额: $ 0.66万
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-31 至 2024-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10975542
• 关键词: TOPIC; 453; DIGITAL; TOOL; INTEGRATE

LucidAct Inc. (LucidAct) is a Digital Health company that offers connected telemedicine and Remote Patient Monitoring (RPM) solutions specifically designed for patients that are non-tech savvy, living in rural areas, or having cultural and/or language barriers. We provide an end-to-end remote care management solution that combines connected medical devices, telehealth, and intelligent patient engagement into a single solution for healthcare organizations. LucidAct platform is cost effective, responsive, and user-friendly for all end-users, including patients, nurses, and physicians. Under this NCI contract, LucidAct will develop a digital tool for cancer prevention, in which we will identify patients that are at high-risk by assessing all potential risk factors including family history, genetics, and environmental factors (tobacco use, diet, obesity, etc.). We will offer science- and guideline-based recommendations to patients to engage in lifestyle changes to reduce cancer risk. LucidAct’s innovative workflow engine is customizable and configurable to manage complex care and to personalize recommendations to each individual patient. We have a team of healthcare and technology professionals that integrate expertise and healthcare data with PCP care and patient expectations to implement smart and usable solutions to complement and extend patient engagement beyond in-person visits.

LucidAct Inc. (LucidAct) 是一家数字健康公司，专门为不懂技术、生活在农村地区或有文化和/或语言障碍的患者提供联网远程医疗和远程患者监护 (RPM) 解决方案。 LucidAct 平台是一种端到端远程护理管理解决方案，它将互联医疗设备、远程医疗和智能患者参与整合到一个针对医疗机构的单一解决方案中，对所有人来说具有成本效益、响应迅速且用户友好。 最终用户，包括患者、护士和医生，根据这份 NCI 合同，LucidAct 将开发一种用于癌症预防的数字工具，我们将通过评估包括家族史、遗传学在内的所有潜在风险因素来识别高风险患者。和环境因素（烟草使用、饮食、肥胖等），我们将为患者提供基于科学和指南的建议，以改变生活方式以降低癌症风险。我们拥有一支由医疗保健和技术专业人员组成的团队，将专业知识和医疗保健数据与 PCP 护理和患者期望相结合，以实施智能且可用的解决方案，以补充和扩大患者参与，超越亲自就诊的范围。